Basel, 04 November 2019
Reminder: Invitation to Roche’s Virtual Early Drug Development pRED Event 2019
We are pleased to invite investors and analysts to participate in a live video webcast and conference call on Monday, 11 November 2019, highlighting Roche’s early drug development with a focus on pRED.
We would like to invite all interested parties to dial in as outlined below:
14:00 - 15:30 CET / 13:00 - 14:30 GMT
08:00 am - 09:30 am EST / 05:00 am - 06:30 am PST
Live audio webcast and conference call will start with presentations by senior management followed by a Q&A session (questions can be asked via phone and webcast).
Karl Mahler, Head of Investor Relations
- Overview and introduction to Roche pRED
William Pao, Head of Roche Pharma Research and Early Development
Christian Rommel, Global Head of pRED Oncology
Azad Bonni, Global Head of pRED Neuroscience and Rare Diseases
Sascha Fauser, Global Head of pRED Ophthalmology
Access to Audio webcast
Please access by clicking on http://ir.roche.com
Access to Conference Call (pre-registration required)
You will receive phone numbers, passcode and your personal PIN to direct access the conference call by pre-registering here.
Should you have any issues with the registration, please dial the following numbers on the day of the conference call 10-15 minutes prior to conference start:
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 631 570 5613 (USA)
A replay of the webcast will be available via http://ir.roche.com